Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

418 results

An image is worth a 1,000 words

15 May 2024 – From EuroPCR 2024

An image is worth a 1,000 words

How to approach isolated ostial left circumflex artery lesion?

15 May 2024 – From EuroPCR 2024

Thanks to this session, explore the role of imaging and physiology in assessing ostial circumflex lesions, examine treatment options for the ostial left circumflex artery, and discuss optimization strategies to enhance long-term outcomes.

How to approach isolated ostial left circumflex artery lesion?

Upper limb subcalvian artery

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the upper limb subclavian artery. Attendees will have the opportunity to explore various challenging cases, including complex double bifurcation trouble, successful management of a subclavian arterial aneurysm, saddle thrombus at the vertebro-subclavian junction, and more....

Upper limb subcalvian artery

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Left main and complex bifurcation stenting

14 May 2024 – From EuroPCR 2024

Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...

Left main and complex bifurcation stenting

Management of patient with complex left main stenosis - LIVE case

14 May 2024 – From EuroPCR 2024

A 52-year-old male, with a history of STEMI treated by PPCI on RCA one month ago, presents with angina CCS 2 and severe, calcified stenosis in the LAD, CX, and distal left main. The treatment involved implanting 2 stents in the LAD after Rota preparation, followed...

Management of patient with complex left main stenosis - LIVE case

Heart team discussion for left main PCI

14 May 2024 – From EuroPCR 2024

This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....

Heart team discussion for left main PCI

When using left ventricular support during PCI

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of left ventricular support devices, such as the Impella, during percutaneous coronary interventions. Attendees will have the opportunity to explore various scenarios, including the management of Impella impaction,...

When using left ventricular support during PCI

DCB PCI in restenosis and de novo lesions

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...

DCB PCI in restenosis and de novo lesions

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI

14 May 2024 – From EuroPCR 2024

This session, with the collaboration of various national societies, focuses on understanding different approaches and techniques for managing challenging situations and complications in patients with ACS and acute heart failure undergoing PCI. It covers the prompt recognition of potential periprocedural complications, various management strategies for PCI...

Challenging situations and complications in patients with ACS and acute heart failure undergoing PCI